Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Preliminary study on the intraoperative application of the “dual-path” strategy for sentinel lymph node tracing in endometrial cancer
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 11 May 2026

Preliminary study on the intraoperative application of the “dual-path” strategy for sentinel lymph node tracing in endometrial cancer

  • Fangyi Huang1 na1,
  • Xinpeng Yao2 na1,
  • Ruyu Shao1,
  • Desheng Yao1,
  • Hooman Soleymani Majd3 &
  • …
  • Yousheng Wei1 

Scientific Reports (2026) Cite this article

  • 432 Accesses

  • 2 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cancer
  • Diseases
  • Medical research
  • Oncology

Abstract

At present, in endometrial cancer surgery, sentinel lymph node tracing via cervical tracer injection is mainly used to assess the metastatic status of pelvic lymph nodes, but it is difficult to evaluate the metastatic status of para-aortic lymph nodes. This study aimed to explore the feasibility of tracing pelvic and para-aortic sentinel lymph nodes drained through different pathways by injecting different tracers via the cervix and proper ovarian ligament respectively during endometrial cancer surgery.A total of 32 patients with endometrial cancer who underwent laparoscopic surgery at the Affiliated Cancer Hospital of Guangxi Medical University from January 2024 to January 2026 were enrolled as the research subjects. Methylene blue solution was injected via the cervix to visualize pelvic sentinel lymph nodes, while indocyanine green (ICG) was injected via the proper ovarian ligament to visualize para-aortic sentinel lymph nodes. The visualization status of sentinel lymph nodes was observed.All sentinel lymph nodes (SLNs) visualized by cervical injection of methylene blue were confined to the pelvic cavity: 92% of lymphatic drainage followed the upper paracervical pathway (UPP), with SLNs located in the obturator and external iliac regions; 8% followed the lower paracervical pathway (LPP), with SLNs in the common iliac region; no infundibulopelvic ligament pathway (IPP) was detected.ICG injection via the proper ovarian ligament visualized SLNs draining through the IPP. The time to initial SLN visualization ranged from 10 s to 137 s (median, 45 s; mean, 50.9 s). Left-sided SLNs were situated in the para-aortic region between the inferior mesenteric artery and left renal vein, with a visualization rate of 80.6% and an accuracy of 95.8%. Right-sided SLNs were located on the inferior vena cava surface 2–3 cm above the aortic bifurcation, with a visualization rate of 93.8% and 100% accuracy. There was no overlap between the visualization pathways of methylene blue and ICG. One case of postoperative lymphatic fistula occurred. The “dual-path” strategy—using different tracers injected via the cervix and proper ovarian ligament to visualize pelvic and para-aortic SLNs respectively—is feasible in endometrial cancer surgery, enabling more comprehensive and accurate assessment of lymph node metastatic status.

Similar content being viewed by others

Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial

Article 04 July 2025

Risk factors of cervical central lymph node metastasis in stage T1a unifocal papillary thyroid carcinoma

Article Open access 26 October 2024

A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes

Article Open access 26 April 2024

Funding

This study was supported by the Science and Technology Program Project of Qingxiu District, Guangxi Zhuang Autonomous Region (Project No.: 2021005), and the AE1/AE3-ICG Fluorescence Imaging Sentinel Lymph Node Research Project (Principal Investigator: Desheng Yao) of the Affiliated Cancer Hospital of Guangxi Medical University.

Author information

Author notes
  1. Fangyi Huang and Xinpeng Yao contributed equally to this work.

Authors and Affiliations

  1. Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Guangxi Zhuang Autonomous Region, Nanning, 530021, P.R. China

    Fangyi Huang, Ruyu Shao, Desheng Yao & Yousheng Wei

  2. Department of cancer and Genomic sciences, College of Medicine and Health, University of Birmingham GB, Birmingham, UK

    Xinpeng Yao

  3. Department of Gynaecology Oncology, Oxford University Hospitals NHS Trust, Oxford, UK

    Hooman Soleymani Majd

Authors
  1. Fangyi Huang
    View author publications

    Search author on:PubMed Google Scholar

  2. Xinpeng Yao
    View author publications

    Search author on:PubMed Google Scholar

  3. Ruyu Shao
    View author publications

    Search author on:PubMed Google Scholar

  4. Desheng Yao
    View author publications

    Search author on:PubMed Google Scholar

  5. Hooman Soleymani Majd
    View author publications

    Search author on:PubMed Google Scholar

  6. Yousheng Wei
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Desheng Yao, Hooman Soleymani Majd or Yousheng Wei.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download PNG )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, F., Yao, X., Shao, R. et al. Preliminary study on the intraoperative application of the “dual-path” strategy for sentinel lymph node tracing in endometrial cancer. Sci Rep (2026). https://doi.org/10.1038/s41598-026-48295-8

Download citation

  • Received: 23 December 2025

  • Accepted: 07 April 2026

  • Published: 11 May 2026

  • DOI: https://doi.org/10.1038/s41598-026-48295-8

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Lymphatic pathway of infundibulopelvic ligament
  • Sentinel lymph node
  • Endometrial cancer
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer